Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): P050104911
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Date: 31-08-2009
Patent type: Salts and Others

Click within the document, or manually enter the page number below

CILFA opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (P060102468)

Countries: Argentina Date: 2009
Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (676/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Countries: India Date: 2009
Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (1638/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Countries: India Date: 2009
Delhi Network of Positive People (DNP+) opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Countries: India Date: 2009
Cipla Ltd. opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Countries: India Date: 2009
Ranbaxy Laboratories opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Countries: India Date: 2009
GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9816239-0 (Divisional to PI9801145-4) )

Countries: Brazil Date: 2009
Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (3383/DELNP/2005)

Countries: India Date: 2009
Matrix Laboratories Ltd. opposition, atazanavir (ATV) , (WO/2013/176772)

Countries: India Date: 2009
Cipla Ltd. opposition, darunavir (DRV) , (1647/DELNP/2004)

Countries: India Date: 2009

Cilfa Opposition, Raltegravir (Ral) , (P050104911)